Manuscript

The impact of liver-directed therapies on the atherogenic risk profile in non-alcoholic steatohepatitis

June 1, 2020

Download

Connelly MA
Rivera JV
Guyton JR
Siddiqui MS
Sanyal AJ

Nephrology Genomics & Genetics